AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75N93021C00021ABVACC, INC.
Overview
Award facts
- Net obligations
- $3.47M
- $3,467,335of $16.93M potential value
- Outlays (paid to date)
- $3.40M
- $3.40M paid of $3.47M obligated$3,404,346
- Period of performance
- May 17, 2021 to Apr 4, 2025
- Ended
- Modifications
- 11
- Latest action Jul 16, 2025
- Contract type
- Definitive contract
- PIID 75N93021C00021
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
TO DEVELOP A POTENT THERAPEUTIC MARBURGVIRUS MONOCLONAL ANTIBODY.
Dates and value
- Award date
- Signed on May 12, 2021
- Potential end of performance
- Apr 3, 2025
- Current value
- $3,467,335Base and exercised options
- Potential value (if all options are exercised)
- $16,927,479
Obligations by fiscal year of action
- FY2025: $21,963
- FY2023: $1,696,004
- FY2021: $1,749,368
Total across 3 fiscal years: $3,467,335
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 16, 2025. View on USAspending · Recipient on SAM.gov
Recipient
NameABVACC, INC.
LocationROCKVILLE, MD
UEIK5MSGRFGVVZ9
CAGE code9FDC1
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyABVACC, INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Rockville, Montgomery County, Maryland 20850-3220
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 23
Solicitation and notices
- Solicitation ID
- HHS-NIH-NIAID-BAA2020-1
- Solicitation date
- Jan 3, 2020
- Notices
- Award Notice posted May 12, 2021
- Award Notice posted May 12, 2021
- Award Notice posted Mar 16, 2021
- Award Notice posted Mar 16, 2021
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 31, 2020
- Award Notice posted Aug 28, 2020
- Award Notice posted Aug 21, 2020
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- May 12, 2021Base obligation at award: $1,749,368
- Latest action
- Jul 16, 2025 — Funding onlyModification P00011; obligation change +$21,963; funding only: changes obligations, not scope
- Latest substantive action
- Apr 7, 2025 — Terminated for convenienceModification P00010
- Latest funding action
- Jul 16, 2025 — Funding onlyModification P00011; obligation change +$21,963; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Other administrative action5
- Funding only3
- Terminated for convenience1
- Option exercised1
- Novation (contract transferred)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $21,963
- Latest action: change in base and all options
- $21,963
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 12
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2021/2021-0885-000
- 075-2023/2023-0885-000
- 075-2025/2025-0885-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression